TY - JOUR
T1 - Value of Automatically Derived Full Thrombus Characteristics
T2 - An Explorative Study of Their Associations with Outcomes in Ischemic Stroke Patients
AU - Mojtahedi, Mahsa
AU - Bruggeman, Agnetha E.
AU - van Voorst, Henk
AU - Ponomareva, Elena
AU - Kappelhof, Manon
AU - van der Lugt, Aad
AU - Hoving, Jan W.
AU - Dutra, Bruna G.
AU - Dippel, Diederik
AU - Cavalcante, Fabiano
AU - Yo, Lonneke
AU - Coutinho, Jonathan
AU - Brouwer, Josje
AU - Treurniet, Kilian
AU - Tolhuisen, Manon L.
AU - LeCouffe, Natalie
AU - Arrarte Terreros, Nerea
AU - Konduri, Praneeta R.
AU - van Zwam, Wim
AU - Roos, Yvo
AU - Majoie, Charles B.L.M.
AU - Emmer, Bart J.
AU - Marquering, Henk A.
N1 - Funding Information:
This project is part of the Artificial Intelligence for Early Imaging Based Patient Selection in Acute Ischemic Stroke (AIRBORNE), which is funded by Top Sector Life Sciences & Health and Nicolab B.V. The funding sources were not involved in the study design, monitoring, data collection, statistical analyses, interpretation of results, or manuscript writing.
Funding Information:
The CONTRAST consortium acknowledges the support from the Netherlands Cardiovascular Research Initiative, which is an initiative of the Dutch Heart Foundation (CVON2015–01: CONTRAST), and from the Brain Foundation Netherlands (HA2015.01.06). The collaboration project is additionally financed by the Ministry of Economic Affairs by means of the PPP Allowance made available by the Top Sector Life Sciences & Health to stimulate public–private partnerships (LSHM17016). This work was funded in part through unrestricted funding by Stryker, Medtronic, and Cerenovus.
Publisher Copyright:
© 2024 by the authors.
PY - 2024/3/1
Y1 - 2024/3/1
N2 - (1) Background: For acute ischemic strokes caused by large vessel occlusion, manually assessed thrombus volume and perviousness have been associated with treatment outcomes. However, the manual assessment of these characteristics is time-consuming and subject to inter-observer bias. Alternatively, a recently introduced fully automated deep learning-based algorithm can be used to consistently estimate full thrombus characteristics. Here, we exploratively assess the value of these novel biomarkers in terms of their association with stroke outcomes. (2) Methods: We studied two applications of automated full thrombus characterization as follows: one in a randomized trial, MR CLEAN-NO IV (n = 314), and another in a Dutch nationwide registry, MR CLEAN Registry (n = 1839). We used an automatic pipeline to determine the thrombus volume, perviousness, density, and heterogeneity. We assessed their relationship with the functional outcome defined as the modified Rankin Scale (mRS) at 90 days and two technical success measures as follows: successful final reperfusion, which is defined as an eTICI score of 2b-3, and successful first-pass reperfusion (FPS). (3) Results: Higher perviousness was significantly related to a better mRS in both MR CLEAN-NO IV and the MR CLEAN Registry. A lower thrombus volume and lower heterogeneity were only significantly related to better mRS scores in the MR CLEAN Registry. Only lower thrombus heterogeneity was significantly related to technical success; it was significantly related to a higher chance of FPS in the MR CLEAN-NO IV trial (OR = 0.55, 95% CI: 0.31–0.98) and successful reperfusion in the MR CLEAN Registry (OR = 0.88, 95% CI: 0.78–0.99). (4) Conclusions: Thrombus characteristics derived from automatic entire thrombus segmentations are significantly related to stroke outcomes.
AB - (1) Background: For acute ischemic strokes caused by large vessel occlusion, manually assessed thrombus volume and perviousness have been associated with treatment outcomes. However, the manual assessment of these characteristics is time-consuming and subject to inter-observer bias. Alternatively, a recently introduced fully automated deep learning-based algorithm can be used to consistently estimate full thrombus characteristics. Here, we exploratively assess the value of these novel biomarkers in terms of their association with stroke outcomes. (2) Methods: We studied two applications of automated full thrombus characterization as follows: one in a randomized trial, MR CLEAN-NO IV (n = 314), and another in a Dutch nationwide registry, MR CLEAN Registry (n = 1839). We used an automatic pipeline to determine the thrombus volume, perviousness, density, and heterogeneity. We assessed their relationship with the functional outcome defined as the modified Rankin Scale (mRS) at 90 days and two technical success measures as follows: successful final reperfusion, which is defined as an eTICI score of 2b-3, and successful first-pass reperfusion (FPS). (3) Results: Higher perviousness was significantly related to a better mRS in both MR CLEAN-NO IV and the MR CLEAN Registry. A lower thrombus volume and lower heterogeneity were only significantly related to better mRS scores in the MR CLEAN Registry. Only lower thrombus heterogeneity was significantly related to technical success; it was significantly related to a higher chance of FPS in the MR CLEAN-NO IV trial (OR = 0.55, 95% CI: 0.31–0.98) and successful reperfusion in the MR CLEAN Registry (OR = 0.88, 95% CI: 0.78–0.99). (4) Conclusions: Thrombus characteristics derived from automatic entire thrombus segmentations are significantly related to stroke outcomes.
KW - artificial intelligence
KW - computed tomography scan
KW - imaging biomarkers
KW - ischemic stroke
KW - thrombus
U2 - 10.3390/jcm13051388
DO - 10.3390/jcm13051388
M3 - Article
SN - 2077-0383
VL - 13
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 5
M1 - 1388
ER -